Drug

Intranasal Ketamine clinical trials

studies test it: 25
open now: 3
in phase 3: 5
first study started: 2001

Keep track of what changes. Save the Intranasal Ketamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Intranasal ketamine: 21
PMI-150 (intranasal ketamine): 2
Ketamine: 2

Studies by the year they started

25 studies that test it; most in 2007 (5)

Studies that test Intranasal Ketamine, by start year
Year	Studies
2001	1
2007	5
2008	1
2014	2
2015	1
2016	3
2017	2
2018	1
2019	1
2020	1
2021	1
2023	2
2024	1
2025	2
2026	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 6
Phase 2: 7
Phase 3: 5
Phase 4: 5
No phase: 4

What it is tested for

Each study’s main condition, where its own words name it.

Depression: 3
Lacerations: 3
Pain, Postoperative: 2
Suicidal Ideation: 1
Cancer Pain: 1
Dental Caries: 1
Abscess: 1
Fractures, Closed: 1
Obsessive-Compulsive Disorder: 1
Breakthrough Pain: 1
Depressive Disorder, Major: 1

Who runs them

Industry 6 · Other 19

Javelin Pharmaceuticals (4) · Hospira, now a wholly owned subsidiary of Pfizer (2) · University of Cincinnati (2) · Tanta University (1) · Zagazig University (1) · Centre for Addiction and Mental Health (1) · The University of Texas Health Science Center, Houston (1) · Emory University (1)

Often tested with

Tested in the same studies.

Midazolam (3) · Dexmedetomidine (2) · Lidocaine (1) · Prilocaine (1)

Studies

Open first, then newest update. How each study uses Intranasal Ketamine is read from its arms, and is right about nine times in ten.

Testing it · 25

See all 25 studies that test Intranasal Ketamine →

Given in every arm · 2 — Intranasal Ketamine is usual care beside what is tested

As the comparator · 3 — what is tested is compared with Intranasal Ketamine